Skip to main content

Table 1 Clinicopathological characteristics and BMP-2 mRNA expression in NSCLC patients (N = 61)

From: Silencing BMP-2 expression inhibits A549 and H460 cell proliferation and migration

Parameter

n

Expression level

P-value

Sex

  

0.415

 Male

29

0.8383 ± 0.13541

 Female

32

0.8692 ± 0.15649

Age (years)

  

0.312

 ≥60

33

0.8369 ± 0.12853

 <60

28

0.8753 ± 0.16512

Differentiation

   

 Well

19

0.8704 ± 0.15222

0.573

 Moderate-poor

42

0.8473 ± 0.14509

 

Tumor stage

  

0.014*

 T1

18

0.8260 ± 0.13904

 T2

31

0.8290 ± 0.14797

 T3–4

12

0.9632 ± 0.1066

TNM stage

  

0.341

 I

26

0.8356 ± 0.13043

 II

22

0.8458 ± 0.17847

 III

13

0.9071 ± 0.11028

Nodal status

  

0.026*

 Positive

28

0.8994 ± 0.15196

 Negative

33

0.8164 ± 0.13218

  1. *Indicates statistical significance (P < 0.05).